![Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/152226/347078/STJ16101720_1__59268.1681999340.jpg?c=1 "Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)")
![Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/1280x1280/products/152226/347078/STJ16101720_1__59268.1681999340.jpg?c=1 "Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)")
Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG2ak
ImmunogenCytoskeletal preparation isolated from microdissected villi of human duodenal mucosa.
General Information
| Short Description | Mouse monoclonal anti-Cytokeratin 20 for use in IHC-P in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC-P |
| Host | Mouse |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | K2 20.8 |
| Isotype | IgG2ak |
| Conjugation | Unconjugated |
| Concentration | >=9, 26 mg/L |
| Dilution Range | IHC-P 1:50 |
| Formulation | PBS (pH 7.6) with 1% BSA and sodium azide |
| Storage Instruction | Store at 2-8°C for up to 1-year, upon receipt. |
Target Information
| Immunogen | Cytoskeletal preparation isolated from microdissected villi of human duodenal mucosa. |
Additional Info
| Background | Cytokeratin 20 has been demonstrated to be almost entirely confined to the gastric and intestinal epithelium, urothelium and Merkel cells of the skin. Cytokeratin 20 is less acidic than other type I cytokeratins and is of interest due to its restricted tissue expression. In normal tissue, cytokeratin 20 is expressed in intestinal epithelium, gastric foveolar epithelium, a number of endocrine cells in the upper portions of the pyloric glands, urothelium and Merkel cells in epidermis. In tumors it is reported, there is a marked difference in the expression of cytokeratin 20 within different carcinomas. Neoplasms expressing cytokeratin 20 are derived from normal epithelia which themselves expressed cytokeratin 20. Colorectal carcinomas consistently express cytokeratin 20, while gastric adenocarcinomas express cytokeratin 20 to a lesser degree. Adenocarcinomas of the gall bladder and bile duct, ductal cell adenocarcinomas of the pancreas, mucinous ovarian tumors, Merkel cell tumors and transitional cell carcinomas have also been reported to express cytokeratin 20. |
Information sourced from Uniprot.org